Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition. Bala Tannan N, Manzari MT, Herviou L, Da Silva Ferreira M, et al. Blood 2021;137:2057-2069.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bala Tannan N, Manzari MT, Herviou L, Da Silva Ferreira M, et al. Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition. Blood 2021;137:2057-2069.
PMID: 33067607